These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


117 related items for PubMed ID: 8203766

  • 1. Study of the antiischemic action of EGb 761 in the treatment of peripheral arterial occlusive disease by TcPo2 determination.
    Mouren X, Caillard P, Schwartz F.
    Angiology; 1994 Jun; 45(6):413-7. PubMed ID: 8203766
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.
    Peters H, Kieser M, Hölscher U.
    Vasa; 1998 May; 27(2):106-10. PubMed ID: 9612115
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings.
    Mix JA, Crews WD.
    Hum Psychopharmacol; 2002 Aug; 17(6):267-77. PubMed ID: 12404671
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD)--a review based on randomized, controlled studies.
    Horsch S, Walther C.
    Int J Clin Pharmacol Ther; 2004 Feb; 42(2):63-72. PubMed ID: 15180165
    [Abstract] [Full Text] [Related]

  • 13. [Gingko biloba extract EGb 761 and pentoxifylline in intermittent claudication. Secondary analysis of the clinical effectiveness].
    Letzel H, Schoop W.
    Vasa; 1992 Feb; 21(4):403-10. PubMed ID: 1485476
    [Abstract] [Full Text] [Related]

  • 14. [Follow-up study, using dynamic transcutaneous oximetry in 17 patients with stage II Leriche and Fontaine occlusive arterial disease of the lower limbs].
    Grard C, Perez-Cousin M, Desmyttère J, Alsberghe MC, Hachulla E, Copin D, Roux JP, Brouillard M, Hatron PY, Warembourg H.
    Rev Med Interne; 1994 Feb; 15(8):510-4. PubMed ID: 7938965
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transcutaneous oxygen pressure measurements in patients with intermittent claudication.
    Rosfors S, Celsing F, Eriksson M.
    Clin Physiol; 1994 Jul; 14(4):385-91. PubMed ID: 7955936
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.
    Kanowski S, Hoerr R.
    Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654
    [Abstract] [Full Text] [Related]

  • 20. [Value of standardized Ginkgo biloba extract (EGb 761) in the management of congestive symptoms of premenstrual syndrome].
    Tamborini A, Taurelle R.
    Rev Fr Gynecol Obstet; 1993 Nov; 88(7-9):447-57. PubMed ID: 8235261
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.